ReachMD

Episodes 1-15 of 17

• • 

    

    Susan O’Brien, MD

    Peer

  • 

    

    Timothy Call, MD

    Peer

  1

  

  RestartResume

  State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL

  State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL

  0.25 credits

• • 

    

    Shaji K. Kumar, MD

    Peer

  • 

    

    María-Victoria Mateos, MD, PhD

    Peer

  1

  

  RestartResume

  Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022

  Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022

  0.25 credits

• • 

    

    Monique Hartley-Brown, MD, MMSc

    Peer

  • 

    

    Shonali Midha, MD

    Peer

  1

  

  RestartResume

  Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma

  Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma

  0.25 credits

• • 

    

    Ian W. Flinn, MD, PhD

    Peer

  • 

    

    William Wierda, MD

    Peer

  1

  

  RestartResume

  Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling: A Multispecialty Approach

  Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling: A Multispecialty Approach

  0.25 credits

• • 

    

    Cesar Rodriquez Valdes, MD

    Peer

  • 

    

    Amrita Krishnan, MD

    Peer

  3

  

  RestartResume

  Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma

  Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma

  0.25 credits

• • 

    

    Amrita Krishnan, MD

    Peer

  • 

    

    Morie Gertz, MD, MACP

    Peer

  2

  

  RestartResume

  Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Relapsed or Refractory Multiple Myeloma

  Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Relapsed or Refractory Multiple Myeloma

  0.25 credits

• • 

    

    Jacob D. Soumerai, MD

    Peer

  • 

    

    Andrew H. Lipsky, MD

    Peer

  2

  

  RestartResume

  Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL

  Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL

  0.25 credits

• • 

    

    Sagar Lonial, MD

    Peer

  • 

    

    Noopur Raje, MD

    Peer

  2

  

  RestartResume

  Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy

  Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy

  0.25 credits

• • 

    

    Amer Zeidan, MBBS

    Peer

  • 

    

    Amy E. DeZern, MD, MHS

    Peer

  3

  

  RestartResume

  Managing and Monitoring MDS: MDS-Related Effects and Progression to AML

  Managing and Monitoring MDS: MDS-Related Effects and Progression to AML

  0.25 credits

• • 

    

    Andrew M. Brunner, MD

    Peer

  • 

    

    Amy E. DeZern, MD, MHS

    Peer

  4

  

  RestartResume

  A New Light in Higher-Risk MDS: Emerging Treatment Options

  A New Light in Higher-Risk MDS: Emerging Treatment Options

  0.25 credits

• • 

    

    Jacqueline Garcia, MD

    Peer

  • 

    

    David A. Sallman, MD

    Peer

  2

  

  RestartResume

  Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Stratifying MDS

  Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Stratifying MDS

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Vivek Subbiah, MD

    Peer

  2

  

  RestartResume

  Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive NSCLC

  Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive NSCLC

  0.25 credits

• • 

    

    Daniel P. Petrylak, MD

    Peer

  • 

    

    Arlene O. Siefker-Radtke, MD

    Peer

  6

  

  RestartResume

  Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma

  Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Justin Gainor, MD

    Peer

  4

  

  RestartResume

  Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC

  Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC

  0.25 credits

• • 

    

    Lauren Ritterhouse, MD ,PhD

    Peer

  • 

    

    Pasi Antero Jänne, MD, PhD

    Peer

  • 

    

    Kanwal Raghav, MD

    Peer

  2

  

  RestartResume

  The Role of HER3 Expression in Advanced Solid Tumors

  The Role of HER3 Expression in Advanced Solid Tumors

  0.50 credits

• 1
• 2
• Next